Announced
Completed
Financials
Sources
Tags
Cross Border
Private
Venture Capital
Biotechnology
Private Equity
Completed
United Kingdom
life sciences software
Acquisition
Minority
Friendly
Synopsis
Horizons Ventures and Sofinnova Partners, two venture capital firms, completed a $35m Series C funding round in Synthace, a life sciences software company. “Synthace’s R&D cloud platform is helping life scientists completely change the way they develop new cures and therapeutics to solve humanity’s most pressing problems. But to maximize impact, we need to expand access and reach to customers across the globe—at scale. This investment serves as a strong vote of confidence from world-class investors in the biopharmaceutical and innovation technology industries. With their support, we’ll be able to better deploy human and financial capital to help transform scientific dreams into drugs and alternative food sources,” Guy Levy-Yurista, Synthace CEO.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.